Labeling and Promotion. Each Product will be marketed in each country with one label and will bear one or more Product Trademarks. All advertising and promotional material in respect of each Product in each country (including any Product labeling or packaging inserts to the extent permitted by law or required by any Regulatory Authority and approved by the Development Committee) will include XOMA's name and address to indicate its role as manufacturer and/or co-promoter, the size and placement of which will be determined by the Development Committee. The Development Committee will be responsible for developing and approving marketing plans and the advertising and other promotional materials to be used in Co-Promoting each Product. In respect of each Co-Promotion country and indication, the Development Committee will determine the Parties' respective responsibilities for seeking acceptance of the relevant Product on formularies, if applicable, and for all other negotiations with managed care organizations and other institutional purchasers.
Labeling and Promotion. Unless otherwise agreed with a Joint Marketing/Development Collaborator: (a) the Licensed Product will be marketed in each country with one label and will bear one or more Product Trademarks; and (b) all advertising and promotional material in respect of the Licensed Product in each country (including any Licensed Product labeling or packaging inserts to the extent permitted by law or required by any Regulatory Authority and approved by the Joint Commercialization Committee) will include both parties' respective name and address, with the size and placement of each such name and address to be determined by the Joint Commercialization Committee.
Labeling and Promotion. To the extent permitted by applicable law and in accord with the Health Registrations, each Product will be marketed with one label and will bear one or more Product trademarks. All advertising and promotional material in respect of the Product (including any Product labeling or packaging inserts to the extent permitted by law or required by any Regulatory Authority and approved by the Company or, if one exists, the marketing committee) will include Sgenia’s, Subco’s and Company’s name and address to indicate its role as patent owner, developer, manufacturer and promoter, the size and placement of which will be determined by the Company or, if one exists, the marketing committee. Each party shall supply the other copies of promotional materials used by it, to facilitate the reasonably necessary exercise of its promotion rights under this Agreement. Company shall not, and shall cause its employees, representatives and agents not, to make any claims or representations in respect of Products that have not been approved by the Health Registrations.
Labeling and Promotion. Subject to Section 2.9(h) of the Agreement, or unless otherwise agreed by the Parties: (a) the Collaboration Product will be marketed in each country with one label and will bear one or more Product Trademarks; and (b) all advertising and promotional material in respect of the Collaboration Product in each country (including any Collaboration Product labeling or packaging inserts to the extent permitted by law or required by any Regulatory Authority and approved by the Joint Commercialization Committee) will include both Parties’ respective name, address and logo, with the size and placement of each such name, address and logo to be equally prominent, and as further determined by the Joint Commercialization Committee.
Labeling and Promotion. Unless otherwise agreed with a Third Party pursuant to Section 5.2 above: (a) each Product will be marketed in each country with one label and will bear one or more Product Trademarks; (b) all advertising and promotional material in respect of each Product in each country (including any Product labeling or packaging inserts to the extent permitted by law or required by any Regulatory Authority and approved by the Commercialization Committee) will include: (i) XOMA's name and address to indicate its role as manufacturer (and co-promoter, if applicable), and (ii) Aphton's name and address to indicate its role with respect to the Commercialization of the Product (if any), with the size and placement of each such name and address to be determined by the Commercialization Committee.
